302.64
+1.89(+0.63%)
Currency In USD
Previous Close | 300.75 |
Open | 302.35 |
Day High | 308.92 |
Day Low | 299.21 |
52-Week High | 377.46 |
52-Week Low | 200.63 |
Volume | 270,967 |
Average Volume | 344,508 |
Market Cap | 6.72B |
PE | -16.97 |
EPS | -17.83 |
Moving Average 50 Days | 293.39 |
Moving Average 200 Days | 296.89 |
Change | 1.89 |
If you invested $1000 in Madrigal Pharmaceuticals, Inc. (MDGL) 10 years ago, it would be worth $3,930.39 as of July 01, 2025 at a share price of $302.64. Whereas If you bought $1000 worth of Madrigal Pharmaceuticals, Inc. (MDGL) shares 5 years ago, it would be worth $2,696.12 as of July 01, 2025 at a share price of $302.64.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
GlobeNewswire Inc.
Jun 20, 2025 10:30 AM GMT
Positive recommendation based on resmetirom’s favorable profile including positive results from the pivotal Phase 3 MAESTRO-NASH trialEuropean Commission decision expected in August 2025; if approved, resmetirom will be the first medication for peopl
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jun 17, 2025 8:05 PM GMT
CONSHOHOCKEN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced tha
Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
GlobeNewswire Inc.
Jun 02, 2025 12:00 PM GMT
CONSHOHOCKEN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46th Annual Global Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40